Strategic Evaluation

Cape Town, South Africa

Strategic Evaluation

Cape Town, South Africa

Time filter

Source Type

News Article | August 3, 2017
Site: marketersmedia.com

— The Global Frozen Foods market has been estimated at USD 230.00 Billion in 2016 and is projected to reach USD 309.98 Billion by 2021, at a CAGR of 6.15% during the forecast period from 2016 to 2021. Frozen foods are the deep frozen food products that can be stored and used over a long time period. It includes foods like meat, vegetables, beans, soups, meals, pizza, and others which are to be preserved and stored at subzero temperatures. Busy lifestyle coupled with shifting preferences among consumers towards ready to cook meals has paved a way for Frozen Foods across the globe. The factors that are driving the market for Frozen Foods across the globe are increase in disposable income coupled with change in lifestyle and food habits, and rapidly increasing large retail chains like hypermarkets and supermarkets. But, the market is feared to decline due to issues like inadequate distribution facility in semi-urban and rural areas, and reliance on third-party distributors to reach retail consumers. Global market for Frozen Foods is segmented based on product type and end- user. By product type, the market is further sub-segmented into frozen ready-to-eat meals, frozen meat & poultry, frozen sea food, frozen vegetables & fruits, frozen potatoes and frozen soup. Frozen ready-to-eat meals segment leads the market, accounting for 35% of the total market, due to increased popularity on account of hygiene and timely preparation. Frozen potatoes segment is anticipated to be the fastest growing segment in the forecast period, with these products having high nutritional value and delicious nature. Geographically, Global market for Frozen Foods is segmented into North America, Asia Pacific, Latin America, Europe, and Middle-East and Africa. Europe accounts for largest share in Frozen foods market, followed by North America. Consumer preference towards hygiene related frozen products, along with restrictions of European Food Safety Authority on usage of artificial flavors and additives accounted for Europe’s largest share in the world market. Asia-Pacific is expected to witness highest growth owing to factors like economic developments paired with increasing urbanization. Kraft Foods Group Inc., Kellogg Company, Nestle S.A., Ajinomoto Co. Inc., Cargill Incorporated, Ralcorp Frozen Bakery Products Inc., Amy’s Kitchen Inc., Unilever plc, The Schwan Food Company, ConAgra Foods Inc., Maple Leaf Foods Inc., General Mills Inc, Heinz, are the major players of Global Frozen Foods market. 4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 4.1 Market Drivers 4.2 Market Restraints 4.3 Key Challenges 4.4 Current Opportunities in the Market 7. Strategic Analysis 7.1 PESTLE analysis 7.1.1 Political 7.1.2 Economic 7.1.3 Social 7.1.4 Technological 7.1.5 Legal 7.1.6 Environmental 7.2 Porter’s Five analysis 7.2.1 Bargaining Power of Suppliers 7.2.2 Bargaining Power of Consumers 7.2.3 Threat of New Entrants 7.2.4 Threat of Substitute Products and Services 7.2.5 Competitive Rivalry within the Industry 8. Market Leaders' Analysis 8.1 Kraft Foods Group Inc. 8.1.1 Overview 8.1.2 Product Analysis 8.1.3 Strategic Evaluation and Operations 8.1.4 Financial analysis 8.1.5 Legal issues 8.1.6 Recent Developments 8.1.7 SWOT analysis 8.1.8 Analyst View 8.2 Kellogg Company 8.3 Nestle S.A. 8.4 Ajinomoto Co. Inc. 8.5 Cargill Incorporated 8.6 Ralcorp Frozen Bakery Products Inc. 8.7 Heinz 8.8 Unilever plc 8.9 The Schwan Food Company 8.10 ConAgra Foods Inc. 8.11 Maple Leaf Foods Inc 8.12 General Mills Inc 9. Competitive Landscape 9.1 Market share analysis 9.2 Merger and Acquisition Analysis 9.3 Agreements, collaborations and Joint Ventures 9.4 New Product Launches For more information, please visit http://www.orbisresearch.com/reports/index/frozen-foods-market-by-product-type-and-by-region-global-industry-analysis-size-share-growth-trends-and-forecasts-2016-2021


Dominique J.K.,Office of Global Research | Ortiz-Osorno A.A.,Clinical Research Implementation Subject Matter Expert | Ortiz-Osorno A.A.,National Institute of Allergy and Infectious Diseases | Fitzgibbon J.,National Institute of Allergy and Infectious Diseases | And 7 more authors.
Clinical Infectious Diseases | Year: 2015

Novel diagnostics have been widely applied across human immunodeficiency virus (HIV) and tuberculosis prevention and treatment programs. To achieve the greatest impact, HIV and tuberculosis diagnostic programs must carefully plan and implement within the context of a specific healthcare system and the laboratory capacity. Methods. A workshop was convened in Cape Town in September 2014. Participants included experts from laboratory and clinical practices, officials from ministries of health, and representatives from industry. Results. The article summarizes best practices, challenges, and lessons learned from implementation experiences across sub-Saharan Africa for (1) building laboratory programs within the context of a healthcare system; (2) utilizing experience of clinicians and healthcare partners in planning and implementing the right diagnostic; and(3) evaluating the effects of new diagnostics on the healthcare system and on patient health outcomes. Conclusions. The successful implementation of HIV and tuberculosis diagnostics in resource-limited settings relies on careful consideration of each specific context.


PubMed | Strategic Evaluation, World Health Organization, Health-U, Adolescent and Pediatric Research Branch and 4 more.
Type: | Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | Year: 2015

Novel diagnostics have been widely applied across human immunodeficiency virus (HIV) and tuberculosis prevention and treatment programs. To achieve the greatest impact, HIV and tuberculosis diagnostic programs must carefully plan and implement within the context of a specific healthcare system and the laboratory capacity.A workshop was convened in Cape Town in September 2014. Participants included experts from laboratory and clinical practices, officials from ministries of health, and representatives from industry.The article summarizes best practices, challenges, and lessons learned from implementation experiences across sub-Saharan Africa for (1) building laboratory programs within the context of a healthcare system; (2) utilizing experience of clinicians and healthcare partners in planning and implementing the right diagnostic; and (3) evaluating the effects of new diagnostics on the healthcare system and on patient health outcomes.The successful implementation of HIV and tuberculosis diagnostics in resource-limited settings relies on careful consideration of each specific context.


Myers J.,University of Cape Town | Young T.,Strategic Evaluation | Galloway M.,Strategic Evaluation | Manyike P.,Strategic Evaluation | And 2 more authors.
South African Medical Journal | Year: 2011

Projections show that the effects of climate change in Africa will not be uniform over the region. The region is extremely vulnerable to climate change because of poverty, a high pre-existing disease burden, fragmented health services and water and food insecurity. Despite the consensus that locally relevant information is necessary to inform policy and practice related to climate change, very few studies assessing the association between climate change and health in southern Africa have been conducted. More comprehensive information is therefore urgently needed for the southern African region to estimate the health risks from projected future changes in climate.


Myers J.,University of Cape Town | Young T.,Strategic Evaluation | Galloway M.,Strategic Evaluation | Manyike P.,Strategic Evaluation | And 2 more authors.
South African Medical Journal | Year: 2011

Anthropogenic climate change and anticipated adverse effects on human health as outlined by the Intergovernmental Panel on Climate Change (IPCC) are taken as givens. A conceptual model for thinking about the spectrum of climate-related health risks ranging from distal and infrastructural to proximal and behavioural and their relation to the burden of disease pattern typical of sub-Saharan Africa is provided. The model provides a tool for identifying modifiable risk factors with a view to future research, specifically into the performance of interventions to reduce the impact of climate change.

Loading Strategic Evaluation collaborators
Loading Strategic Evaluation collaborators